FDA Warning Letter — Strive Pharmacy Texas LLC

Case 639220 — FEI 3015826784

The FDA took a Warning Letter action against Strive Pharmacy Texas LLC on Aug 30, 2022 (Boerne, TX). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Strive Pharmacy Texas LLC
Date
Aug 30, 2022
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
Boerne, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.